Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03738462 · ClinicalTrials.gov registry record
A Study to Evaluate the Conformis Hip System
A clinical trial, sponsored by Restor3D.
- Terminated
- Registry status
- 49
- Enrollment target
NCT03738462 is a clinical trial that was terminated before completion, run by Restor3D. The registered enrollment target is 49 participants.
The verdict
NCT03738462 was terminated before completion, sponsored by Restor3D.
- TERMINATED
- Registry status
- 49 participants
- Enrollment target
Study Summary
This is a prospective multicenter study. Subjects will be implanted with a Conformis Hip System. If the surgeon intraoperatively decides to use the Cordera femoral stem, these patients will also be enrolled in the study and tracked as a subset of the Conformis Hip System patient population.The study sites will be located in the United States. The study subjects will be followed for 10 years post implantation.
Interventions
- DEVICE Conformis Hip System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2018-11-26 |
| Est. Completion | 2022-06-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03738462
The ClinicalTrials.gov registry entry for NCT03738462 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Restor3D, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Conformis Hip System is the first listed.
NCT03738462 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03738462 about?
NCT03738462 is a clinical study titled "A Study to Evaluate the Conformis Hip System". This is a prospective multicenter study. Subjects will be implanted with a Conformis Hip System. If the surgeon intraoperatively decides to use the Cordera femoral stem, these patients will also be enrolled in the study and tracked as a subset of the Conformis Hip System patient population.The study...
What is the current status of trial NCT03738462?
This trial is currently terminated. The enrollment target is 49 participants. The study started on 2018-11-26. Estimated completion is 2022-06-06.
What interventions are being tested in trial NCT03738462?
The interventions under investigation include: Conformis Hip System (DEVICE).
Who is sponsoring clinical trial NCT03738462?
This trial is sponsored by Restor3D, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.